<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A great variety of autoimmune side effects have been reported during interferon alpha therapy </plain></SENT>
<SENT sid="1" pm="."><plain>The presence of anticardiolipin antibodies during interferon alpha therapy in <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C has also been reported </plain></SENT>
<SENT sid="2" pm="."><plain>There are no reports on the occurrence of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C while on pegylated interferon alpha therapy </plain></SENT>
<SENT sid="3" pm="."><plain>We report a case of a 46-year-old man who developed <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> 12 weeks after starting pegylated interferon alpha plus ribavirin for <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C </plain></SENT>
<SENT sid="4" pm="."><plain>The clinical presentation of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> was <z:hpo ids='HP_0008207'>primary adrenal insufficiency</z:hpo> secondary to bilateral adrenal haematoma and subclavian vein <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>A pathogenic role of pegylated interferon alpha as a trigger factor for <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> development is suggested </plain></SENT>
</text></document>